No registrations found.
ID
Source
Brief title
Health condition
atopic dermatitis
atopic eczema
wet-wrap therapy
atopisch eczeem
constitutioneel eczeem
emollients
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main endpoint concerns the comparison of the decrease of the objective SCORAD between the two groups for the various time points (=comparison of efficacy of the two therapies).
Secondary outcome
One secondary endpoint is the change of serum markers levels at various time points in the two groups and the correlation of the serum markers levels to the objective SCORAD (=development of an effective and objective value for monitoring the severity of AD)
Another secondary endpoint is change in quality of life-score at the beginning and the end of the study in the two groups and the correlation of the quality of life score to the objective SCORAD and the serum markers.
Background summary
Rationale: Throughout the world, wet wrap therapy is advocated by dermatologists for treatment of children with severe atopic dermatitis. However, there is no consensus regarding the best method for wet wrap therapy with respect to the ointment or cream to be used under the wet dressings.
Objective: The main objective of this study is to compare the efficacy of wet wrap therapy with diluted corticosteroids versus wet wrap therapy with emollients. The secondary objectives are to develop an effective and objective value for monitoring the severity of atopic dermatitis, to monitor quality of life during therapy and to evaluate the safety of both therapies.
Study design: A prospective, double-blind, randomised, multi center intervention study.
Study population: Children 6 months-6 years old with severe atopic dermatitis (objective SCORAD ¡Ý 40).
Intervention: Patients will be randomised over 2 groups: the first group receives therapy with diluted corticosteroid cream under wet wraps and the second group receives emollients under wet-wraps.
Main study endpoint: The main endpoint of the study is the comparison of the decrease of the objective SCORAD between the two groups for the various time points.
Study objective
Wet-wrap treatment with diluted corticosteroids is more effective than wet-wrap treatment with emollients only
Study design
Day 1, 4, 7, 14, 28.
Intervention
Wet-wrap therapy with diluted corticosteroid cream (mometason-furoaat with vaseline 20% cetomacrogolcream dilution 1:19 face and 1:3 body) vs. wet-wrap therapy with emollients (vaseline 20% cetomacrogolcream).
Erasmus MC en KinderHaven, Rotterdam
Arnold P. Oranje
Rotterdam
The Netherlands
+31(010) 703 6656/6653/2697 of (010) 404 3700
a.p.oranje@erasmusmc.nl
Erasmus MC en KinderHaven, Rotterdam
Arnold P. Oranje
Rotterdam
The Netherlands
+31(010) 703 6656/6653/2697 of (010) 404 3700
a.p.oranje@erasmusmc.nl
Inclusion criteria
1. Age 6 months - 6 years at inclusion
2. Diagnosis of atopic dermatitis with an objective SCORAD > 40
3. Parent/legal guardian willing to comply with the protocol
4. Written, dated consent for subject to participate
Exclusion criteria
1. Known pre-existing, serious underlying disease
2. (Secondary) infected eczema:
- In case of overt impetiginisation, wet wrapping should be delayed until 48-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results
- Eczema herpeticum is an absolute contraindication for the use of wet dressings
3. Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38.3ºC)
4. Problems in the hypothalamus-pituitary-adrenal (HPA) axis
5. Systemic corticosteroid therapy
6. Severe growth retardation
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1201 |
NTR-old | NTR1246 |
Other | MEC : 2008-077 |
ISRCTN | ISRCTN wordt niet meer aangevraagd |